journal
https://read.qxmd.com/read/38870920/geriatric-assessment-scale-for-optimal-management-of-gastric-cancer-in-older-adults-who-underwent-gastrectomy-a-systematic-review
#1
JOURNAL ARTICLE
Brenda Rodriguez-Arroyo, Pedro Caraballo, Alejandro Pineda-Isaza, Oriana Arias-Valderrama, Manuel A Cleves, Angela R Zambrano
INTRODUCTION: Stomach cancer is one of the most common causes of cancer worldwide, especially in the population over 65 years, the survival rate is less in comparison with young people, the evaluation of geriatric assessment would be key for assessing the prognosis of these patients. METHODS: A search was performed in the OVID, EMBASE and PUBMED databases, and after applying inclusion and exclusion criteria, four (4) articles were analyzed. RESULTS: In the included studies, the MGA battery was not implemented, but rather easily measurable scales as nutritional status, functional status, cognitive and behavioral disorders, comorbidities, and polypharmacy, some authors proposed through the assessment of overall survival is not explicit among the included studies, patients with gastric cancer and mild, moderate, severe, and total dependence had a higher mortality than independent patients (39% HR 1...
June 13, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38763125/stereotactic-radiotherapy-for-penile-metastasis-case-report-and-systematic-literature-review
#2
Antonio Piras, Andrea D'Aviero, Antonella Sanfratello, Luca Boldrini, Gianfranco Pernice, Massimiliano Spada, Gianluca Gaudio, Mirko Pinelli, Giuseppe Salamone, Vittorio Gebbia, Nino Dispensa, Gabriele Tulone, Riccardo Laudicella, Albert Comelli, Domenico Di Raimondo, Antonino Tuttolomondo, Tommaso Angileri, Antonino Daidone
Introduction Penile metastases (PM) are a rare clinical presentation mainly related to advanced stages of disease. Considering the low incidence, an optimal treatment approach has not yet been defined; surgery, chemotherapy, and radiotherapy are different options used in the vast majority with palliative intent. The advances in modern RT can represent an innovative tool in PM management and a curative option. This paper aims to report the case of a PM patient treated with Stereotactic Body Radiotherapy (SBRT) and perform a systematic literature review of current evidence on the RT approach to PM...
May 18, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38754400/a-multicentre-randomized-trial-in-adults-with-de-novo-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-to-assess-the-efficacy-of-ponatinib-versus-imatinib-in-combination-with-low-intensity-chemotherapy-to-compare-end-of-therapy-with-indication
#3
JOURNAL ARTICLE
Fabian Lang, Heike Pfeifer, Monika Brüggemann, Eva Hermann, Hubert Serve, Nicola Goekbuget
Introduction Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) is treated as standard of care (SoC) by imatinib based treatment combined with induction and consolidation chemotherapy followed by allogeneic stem cell transplantation (SCT) in first remission. The German Multicenter ALL Study Group for Adult ALL (GMALL) reports about a trial to evaluate the impact of ponatinib based therapy, blinatumomab (blina) treatment for suboptimal responders and the possibility of omission of SoC Allo SCT in optimal responders entitled GMALL-EVOLVE...
May 16, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38714183/what-do-german-molecular-tumor-boards-recommend-in-patients-with-pik3ca-mutated-tumors-launch-and-first-results-from-the-german-team-d-transsectoral-molecular-tumor-board-exchange-platform-deutschland-team-d
#4
JOURNAL ARTICLE
Ina Pretzell, Alexander Desuki, Annalen Bleckmann, Sonja Loges, Anke Reinacher-Schick, C Benedikt Westphalen, Sebastian Lange
BACKGROUND AND RATIONALE: Comprehensive molecular tumor profiling is widely used in the management of patients with cancer. Molecular tumor boards devise treatment strategies based on testing results. In this setting, the Transsectoral Molecular Tumor Board exchange platform Deutschland (TEAM-D) aims to drive peer-to-peer exchange to connect experts in the field. METHODS: During the first virtual TEAM-D meeting, participants from 16 German universities and 5 nonacademic institutions discussed five cases with PIK3CA hotspot mutations...
May 7, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38714181/anaemia-in-hospitalized-cancer-patients-a-retrospective-study-of-two-cohorts-before-and-after-the-guideline-update
#5
JOURNAL ARTICLE
Katell Le Dû, Anne-Lise Septans, Julien Dômont, Olivier Dupuis, Eric Emmanuel, Anne Peribois, Sophie Gaillard, Caroline Allix-Béguec
Introduction The incidence of anaemia and its consequences are often underestimated during cancer management. We propose to evaluate the situation before and after the recommendations were updated in order to assess their impact on the day-to-day practice. Methods In this single-center retrospective study, eligible patients were treated for cancer and warranted overnight hospitalization over two periods (n=206 in 2011, n=143 in 2018). The diagnosis of anaemia was defined by a hemoglobin level below 12 and 13 g/dl for women and men, respectively...
May 7, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38714178/evaluation-of-the-impact-of-adaptive-progressive-supervised-resistance-training-on-strength-and-quality-of-life-in-patients-with-breast-cancer-during-chemotherapy-the-valesco-study
#6
JOURNAL ARTICLE
Lars Gerland, Nadia Harbeck, Susanne Frisse, Wilhelm Bloch, Wolfram Malter, Ronald Kates, Freerk Theeagnus Baumann
INTRODUCTION: Breast Cancer Patients (BCP) experience considerable side effects during and after treatment. Several studies have shown positive effects of exercise on therapy-related side-effects such as loss of muscle strength, loss of bone mineral density, lymphedema and several elements of quality of life (QoL). Resistance exercise has proven effective and beneficial for BCP; however optimal individual training parameters remain to be determined. METHODS: The aim of our study was to implement an adaptive, progressive, supervised resistance protocol for breast cancer patients during chemotherapy, improving muscle strength, physical condition, and overall QoL while reducing therapy-induced side-effects...
May 7, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38636467/association-between-metabolic-reprogramming-and-immune-regulation-in-digestive-tract-tumors
#7
REVIEW
Jiafeng Liu, Tianxiao Wang, Wenxin Zhang, Yuxin Huang, Xinhai Wang, Qunyi Li
BACKGROUND: The cancers of the digestive tract, including colorectal cancer (CRC), gastric cancer (GC) and Esophageal cancer (ESCA), are part of the most common cancers as well as one of the most important leading causes of cancer death worldwide. SUMMARY: Despite the emergence of immune checkpoint inhibitors (e.g., anti-CTLA-4 and anti-PD-1/PD-L1) in the past decade, offering renewed optimism in cancer treatment, only a fraction of patients derive benefit from these therapies...
April 18, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38636466/metastases-affecting-cranial-nervous-structures-in-male-breast-cancer-two-cases-report
#8
Andrea Valera-Barrero, Jorge Madera-Fernández, Vicente González-Quintanilla, María José Sedano-Tous, Francisco Martínez Dubarbie
INTRODUCTION: Breast cancer in males is a very rare entity, and survival is mainly influenced by the stage at diagnosis. The lack of early detection tools in men results in a diagnostic delay of about 5-10 years and a higher percentage of metastatic disease at diagnosis. However, the characteristics of head metastases are not well defined. CASE REPORTS: We present two cases of male breast cancer with metastases affecting cranial nervous structures and we provide imaging and histologic data...
April 18, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38583428/high-dose-chemotherapy-and-autologous-stem-cell-transplantation-for-salvage-therapy-of-relapsed-refractory-germ-cell-tumors-a-single-center-experience
#9
JOURNAL ARTICLE
Gul Sema Yıldıran Keskin, Ismail Ertürk, Musa Baris Aykan, Ramazan Acar, Aysegul Dumludag, Alper Topal, Caglar Koseoglu, Omer Faruk Kuzu, Ece Ornek, Nuri Karadurmus
PURPOSE: The optimal management of relapsed/refractory germ cell tumors remains unsettled. In this study, we aimed to evaluate the efficacy of high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) as salvage therapy in patients who progressed after at least one line of cisplatin-based chemotherapy. METHODS: We retrospectively reported the results of 133 patients who underwent HDCT and ASCT as salvage therapy from 2016 to 2021. Patients received 3 cycles of paclitaxel, ifosfomide and cisplatin (TIP) regimen as induction and 1 cycle of carboplatin 700 mg/m2 on days 1 to 3 plus etoposide 750 mg/m2 on days 1 to 3, followed by ASCT...
April 5, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38583422/intradermal-naked-dna-vaccination-by-dna-tattooing-for-mounting-tumor-specific-immunity-in-stage-iv-melanoma-patients-a-phase-i-clinical-trial
#10
JOURNAL ARTICLE
Marnix H Geukes Foppen, Maartje W Rohaan, Jessica S W Borgers, Daisy Philips, Florry Vyth-Dreese, Jos H Beijnen, Bastiaan Nuijen, Joost H van den Berg, John B A G Haanen
INTRODUCTION: Naked DNA vaccination could be a powerful and safe strategy to mount antigen-specific cellular immunity. We designed a phase I clinical trial to investigate the toxicity of naked DNA vaccines encoding CD8+ T-cell epitope from tumor-associated antigen MART-1 in patients with advanced melanoma. METHODS: This dose escalating phase Ia clinical trial investigates the toxicity and immunological response upon naked DNA vaccines encoding a CD8+ T-cell epitope from the tumor-associated antigen MART-1, genetically linked to the gene encoding domain 1 of subunit-tetanus toxin fragment C in patients with advanced melanoma (inoperable stage IIIC-IV, AJCC 7th edition)...
April 5, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38574467/thoracic-oncology-highlights-from-the-european-society-for-medical-oncology-annual-meeting-2023-with-focus-on-perioperative-therapy-radiotherapy-and-bites
#11
LETTER
Marcel Kemper, Puyan Soltani Germy, Fabian Acker, Jingting Luan, Frank Griesinger, Amanda Tufman, Cornelia Kropf-Sanchen, Tobias R Overbeck, Annalen Bleckmann, Miriam Blasi
No abstract text is available yet for this article.
April 4, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38565096/clinicopathologic-features-and-efficacy-of-induction-chemotherapy-in-nasopharyngeal-carcinoma-real-world-experience
#12
JOURNAL ARTICLE
Nargiz Majidova, Murat Sari, Fatma Akdag Kahvecıglu, Erkan Ozcan, Mutıanur Ozkorkmaz Akdag, Akıf Dogan, Sedat Yıldırım, Sermın Dınc Sonusen, Emıl Yunusov, Alper Yasar, Abdussamet Celebi, Nadıye Sever, Erkam Kocaaslan, Pınar Erel, Yesım Agyol, Ali Kaan Guren, Rukiye Arikan, Selver Işık, Ozlem Balvan, Caglayan Geredeli, Kazım Uygun, Ilhan Hacıbekiroğlu, Osman Kostek, İbrahim Vedat Bayoğlu
INTRODUCTION: Nasopharyngeal carcinoma (NPC) accounts for 0.01% of all carcinomas, and 70% of patients have locally advanced disease with a poor prognosis. The mainstay therapy is chemoradiotherapy (CRT), and concurrent administration of platinum-based agents and irradiation provides high local control rates. However, induction (neoadjuvant) chemotherapy (ICT) prior to chemoradiotherapy is recommended for large tumors with a high tumor burden at category 1 level. For induction chemotherapy, platinum-based doublet or triplet combination regimens are recommended...
April 2, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38565089/adjuvant-treatment-with-s-1-in-patients-after-r0-resection-of-adenocarcinoma-of-the-stomach-and-esophagogastric-junction-a-multicenter-phase-i-ii-feasibility-study-gmbh-sto-0114
#13
JOURNAL ARTICLE
Kathrin Heinrich, Volker Heinemann, Sebastian Stintzing, Lothar Müller, Thomas J Ettrich, Petra Buechner-Steudel, Michael Geißler, Jörg Trojan, Nicolas Moosmann, Gunnar Folprecht, Johannes Schmidt, Stephan Kanzler, Frank Kullmann, Jean-Charles Moulin, Jens Werner, Martin K Angele, Victoria Probst, Swantje Held, Christoph Schulz, Myrto Boukovala
INTRODUCTION: S-1 has been shown to be an effective adjuvant treatment option for East Asian patients who underwent gastrectomy for stage II/III gastric cancer. We conducted a phase I/II study to evaluate the feasibility, tolerability and efficacy of administering S-1 in the adjuvant setting after R0-resection of adenocarcinoma of the stomach and esophagogastric junction (EGJ) in Caucasian patients. METHODS: In this single-cohort, open-label, phase I/II trial, we enrolled patients with locally advanced adenocarcinoma of the stomach or EGJ having undergone R0-resection with or without neoadjuvant treatment...
April 2, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38527447/thoracic-oncology-highlights-from-the-european-society-for-medical-oncology-annual-meeting-2023-with-focus-on-targeted-therapies
#14
LETTER
Fabian Acker, Jingting Luan, Puyan Soltani Germy, Marcel Kemper, Miriam Blasi, Frank Griesinger, Amanda Tufman, Annalen Bleckmann, Cornelia Kropf-Sanchen, Tobias R Overbeck
No abstract text is available yet for this article.
March 25, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38493778/ambulatory-routine-care-in-oncology-in-germany-real-world-survival-data
#15
JOURNAL ARTICLE
Norbert Marschner, Wolfgang Knauf
INTRODUCTION: Survival data reported by randomised controlled trials are collected in a highly selected patient population and can thus only be transferred to a limited extent to real-world patients: the patients in routine care are mostly older, present with more comorbidities and a worse general state of health. This so-called efficacy-effectiveness gap typically results in inferior survival data in routine healthcare. METHODS: Six prospective clinical tumour registries recruited a total of 11,679 patients receiving systemic therapy in haemato-oncological practices in Germany between 2006 and 2020...
March 15, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38493777/enhanced-survival-with-lymphadenectomy-in-early-stage-metachronous-second-primary-lung-cancer-a-retrospective-analysis
#16
JOURNAL ARTICLE
Jieshi Zhang, Yuxiao Lin, Jiong Zhou, Ruixuan Geng, Zhibo Zheng, Chao Guo, Xiaojun Ma, Shanqing Li
INTRODUCTION: Lymphadenectomy is a cornerstone in the surgical management of resectable primary lung cancer. However, its prognostic significance in early-stage metachronous second primary lung cancer(MSPLC) remains poorly understood. This retrospective study aims to evaluate the prognostic impact of lymphadenectomy in these patients using data from the Surveillance, Epidemiology, and End Results (SEER) Database. METHODS: A retrospective cohort study was conducted using data from the SEER Database for patients surgically treated for stage I MSPLC between 2004 and 2015...
March 15, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38484712/prioritization-and-resource-allocation-in-the-context-of-the-covid-19-pandemic-recommendations-for-colorectal-and-pancreatic-cancer-in-germany
#17
Celine Lugnier, Sabine Sommerlatte, Ulrike Attenberger, Ambros J Beer, Martin Bentz, Stefan R Benz, Thomas Birkner, Jens Büntzel, Matthias Ebert, Peter Fasching, Wolfgang Fischbach, Emmanouil Fokas, Birgit Fricke, Helene Hense, Erich Grohmann, Ralf-Dieter Hofheinz, Dietrich Hüppe, Stefan Huster, Patrick Jahn, Monika Klinkhammer-Schalke, Wolfgang Knauf, Anna-Lena Kraeft, Bernd Oliver Maier, Georg Marckmann, Günter Niegisch, Lutz Otto, Uwe Pelzer, Pompiliu Piso, Henning Rosenau, Jochen Schmitt, Olaf Schoffer, Jalid Sehouli, Andrea Tannapfel, Ulrich Wedding, Simone Wesselmann, Eva C Winkler, Tanja Zimmermann, Bernhard Wörmann, Anke Reinacher-Schick, Jan Schildmann
In the context of the COVID-19 pandemic, there has been a scarcity of resources with various effects on the care of cancer patients. This paper provides an English summary of a German guideline on prioritization and resource allocation for colorectal and pancreatic cancer in the context of the pandemic. Based on a selective literature review as well as empirical and ethical analyses, the research team of the CancerCOVID Consortium drafted recommendations for prioritizing diagnostic and treatment measures for both entities...
March 14, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38479362/gastroesophageal-oncology-highlights-from-the-european-society-for-medical-oncology-annual-meeting-2023
#18
LETTER
Magdalena K Scheck, Ira Ekmekciu, Greta Sommerhäuser, Christian Heise, Ilektra Antonia Mavroeidi, Volker Kunzmann, Henning Wege, Anke Reinacher-Schick, Ralf-Dieter Hofheinz, Thorsten Oliver Götze, Sylvie Lorenzen, Alexander Nieto
No abstract text is available yet for this article.
March 13, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38471487/associations-of-dietary-factors-with-cutaneous-melanoma-a-case-control-study-in-greece-with-literature-review
#19
JOURNAL ARTICLE
Andreas Katsimpris, Antonios G Antoniadis, Nick Dessypris, Konstantinos Karampinos, Helen J Gogas, Eleni Th Petridou
INTRODUCTION: It has been postulated that nutrition may influence the risk for cutaneous melanoma (CM); therefore, we aimed to assess the associations of food groups and individual nutrient intakes with CM in a Greek population. METHODS: In this case-control study, 151 patients with histologically confirmed CM, newly diagnosed and treated in the Oncology Department of the 'Laikon' University Hospital (Athens, Greece), and 151 age- and sex-matched healthy individuals residing in the Athens metropolitan area, recruited among participants for routine health examinations were included...
March 12, 2024: Oncology Research and Treatment
https://read.qxmd.com/read/38471462/cancer-related-cognitive-dysfunction-a-narrative-review-for-clinical-practice
#20
REVIEW
Oliver Rick, Alexandra Gerhardt, Georgia Schilling
BACKGROUND: Cancer-related cognitive dysfunction (CRCD) is a major functional disorder in patients with cancer. This central nervous dysfunction is found in up to 60 % of patients after tumour therapy, often significantly limits the quality of life and significantly impedes participation in working life. For this reason, diagnosis and treatment of CRCD is of central importance. This narrative review is intended to provide an overview and support for practical clinical care with regard to diagnostics and therapeutic options...
March 12, 2024: Oncology Research and Treatment
journal
journal
48348
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.